Research ArticleOriginal Article
Open Access

D-dimer as a predictive and prognostic marker among COVID-19 patients

Ahmed M. E. Elkhalifa
Saudi Medical Journal July 2022, 43 (7) 723-729; DOI: https://doi.org/10.15537/smj.2022.43.7.20220213

References

  1. 1.↵
    1. Huang C,
    2. Wang Y,
    3. Li X,
    4. Ren L,
    5. Zhao J,
    6. Hu Y, et al.
    Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Johns Hopkins Coronavirus Resource Center. Disparity Explorer. [Updated 2022; accessed 2022 May 22]. Available from: https://coronavirus.jhu.edu/data/disparity-explorer
  3. 3.↵
    Ministry of Health. COVID-19 dashboard: Saudi Arabia. [Updated 2020; accessed 2022 May 22]. Available from: https://covid19.moh.gov.sa/
  4. 4.
    1. Alyami MH,
    2. Naser AY,
    3. Orabi MAA,
    4. Alwafi H,
    5. Alyami HS.
    Epidemiology of COVID-19 in the Kingdom of Saudi Arabia: an ecological study. Front Public Health 2020; 8: 506.
    OpenUrl
  5. 5.↵
    1. Ahmed NJ.
    Cross-sectional study of prevalence of COVID-19 in Alkharj, Saudi Arabia. J Pharm Res Int 2020; 32: 184–188.
  6. 6.↵
    1. Ebrahim SH,
    2. Memish ZA.
    Saudi Arabia’s drastic measures to curb the COVID-19 outbreak: temporary suspension of the Umrah pilgrimage. J Travel Med 2020; 27: taaa029.
  7. 7.
    1. Wang D,
    2. Hu B,
    3. Hu C,
    4. Zhu F,
    5. Liu X,
    6. Zhang J, et al.
    clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061–1069.
    OpenUrlCrossRefPubMed
  8. 8.
    1. Mattiuzzi C,
    2. Lippi G.
    Which lessons shall we learn from the 2019 novel coronavirus outbreak? Ann Transl Med 2020; 8: 48.
    OpenUrl
  9. 9.↵
    1. Levi M,
    2. Thachil J,
    3. Iba T,
    4. Levy JH.
    Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol 2020; 7: e438–e440.
    OpenUrlPubMed
  10. 10.↵
    1. Chen N,
    2. Zhou M,
    3. Dong X,
    4. Qu J,
    5. Gong F,
    6. Han Y, et al.
    Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507–513.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Zhang Y,
    2. Xiao M,
    3. Zhang S,
    4. Xia P,
    5. Cao W,
    6. Jiang W, et al.
    Correspondence coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med 2020; 382: e38.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Abd El-Lateef AE,
    2. Alghamdi S,
    3. Ebid G,
    4. Khalil K,
    5. Kabrah S,
    6. Abdel Ghafar MT.
    Coagulation profile in COVID-19 patients and its relation to disease severity and overall survival: a single-center study. Br J Biomed Sci 2022; 79: 10098.
    OpenUrl
  13. 13.↵
    1. Aires RB,
    2. Soares AASM,
    3. Gomides APM,
    4. Nicola AM,
    5. Teixeira-Carvalho A,
    6. da Silva DLM, et al.
    Thromboelastometry demonstrates endogenous coagulation activation in nonsevere and severe COVID-19 patients and has applicability as a decision algorithm for intervention. PLoS One 2022; 17: e0262600.
    OpenUrl
  14. 14.↵
    1. Long X,
    2. Zhang Z,
    3. Zou W,
    4. Ling J,
    5. Li D,
    6. Jing L, et al.
    Coagulopathy of patients with COVID-19 is associated with infectious and inflammatory markers. Risk Manag Healthc Policy 2020; 13: 1965–1975.
    OpenUrl
  15. 15.↵
    1. Savioli F,
    2. Rocha LL.
    Coagulation profile in severe COVID-19 patients: what do we know so far? Rev Bras Ter Intensiva 2020; 32: 197–199.
    OpenUrl
  16. 16.↵
    1. Chan NC,
    2. Weitz JI.
    COVID-19 coagulopathy, thrombosis, and bleeding. Blood 2020; 136: 381–383.
  17. 17.↵
    1. Al-Samkari H,
    2. Karp Leaf RS,
    3. Dzik WH,
    4. Carlson JCT,
    5. Fogerty AE,
    6. Waheed A, et al.
    COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood 2020; 136: 489–500.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Tang N,
    2. Li D,
    3. Wang X,
    4. Sun Z.
    Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18: 844–847.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Cheung CKM,
    2. Law MF,
    3. Lui GCY,
    4. Wong SH,
    5. Wong RSM.
    Coronavirus disease 2019 (COVID-19): a haematologist’s perspective. Acta Haematol 2021; 144: 10–23.
    OpenUrl
  20. 20.↵
    1. Khurana D,
    2. Deoke SA.
    Thrombocytopenia in critically ill Patients: Clinical and Laboratorial Behavior and Its Correlation with short-term outcome during hospitalization. Indian J Crit Care Med 2017; 21: 861–864.
    OpenUrl
  21. 21.↵
    1. Lippi G,
    2. Plebani M,
    3. Henry BM.
    Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 2020; 506: 145–148.
    OpenUrlCrossRefPubMed
  22. 22.↵
    World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance 28 January 2020. [Updated 2020; accessed 2021 Feb 9]. Available from: https://apps.who.int/iris/handle/10665/330893?search-result=true&query=Clinical+management+of+severe+acute+respiratory+infection+when+novel+coronavirus+%282019-nCoV%29+infection+is+suspected%3A+interim+guidance+28+January+2020&scope=&rpp=10&sort_by=score&order=desc
  23. 23.↵
    Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7). Chin Med J (Engl) 2020; 133: 1087–1095.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Pagana KD,
    2. Pagana TJ,
    3. Pagana TN.
    Mosby’s Diagnostic and Laboratory Test Reference. [Updated 2019; accessed 2022 Mar 2]. Available from: https://evolve.elsevier.com/cs/product/9780323609678?role=student
  25. 25.↵
    World Health Organization - China Joint Mission. Report of the WHO-China Joint Mission on coronavirus disease 2019 (COVID-19). [Updated 2020; accessed 2022 Mar 12]. Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
  26. 26.↵
    1. Roy D,
    2. Tripathy S,
    3. Kar SK,
    4. Sharma N,
    5. Verma SK,
    6. Kaushal V.
    Study of knowledge, attitude, anxiety & perceived mental healthcare need in Indian population during COVID-19 pandemic. Asian J Psychiatr 2020; 51: 102083.
    OpenUrlPubMed
  27. 27.↵
    1. Eastin C,
    2. Eastin T.
    Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. J Emerg Med 2020; 58: 712–713.
    OpenUrlCrossRef
  28. 28.↵
    1. Elderdery AY,
    2. Elkhalifa AME,
    3. Alsrhani A,
    4. Zawbaee KI,
    5. Alsurayea SM,
    6. Escandarani FK, et al.
    Complete blood count alterations of COVID-19 patients in Riyadh, Kingdom of Saudi Arabia. [Updated 2022; accessed 2022 May 22]. Available from: https://www.hindawi.com/journals/jnm/2022/6529641/
  29. 29.↵
    1. Elkhalifa AME,
    2. Elderdery AY,
    3. Al Bataj IA,
    4. Tamomh AG,
    5. Alyami MM,
    6. Almakrami HA, et al.
    Hematological findings among COVID-19 patients attending King Khalid Hospital at Najran, Kingdom of Saudi Arabia. Biomed Res Int 2022; 2022: 4620037.
    OpenUrl
  30. 30.↵
    1. Zhou F,
    2. Yu T,
    3. Du R,
    4. Fan G,
    5. Liu Y,
    6. Liu Z, et al.
    Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054–1062.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Yamada H,
    2. Okamoto M,
    3. Nagasaki Y,
    4. Yoshio S,
    5. Nouno T,
    6. Yano C, et al.
    Analysis of early biomarkers associated with the development of critical respiratory failure in coronavirus disease 2019 (COVID-19). Diagnostics (Basel) 2022; 12: 339.
    OpenUrl
  32. 32.↵
    1. Kolifarhood G,
    2. Aghaali M,
    3. Mozafar Saadati H,
    4. Taherpour N,
    5. Rahimi S,
    6. Izadi N, et al.
    Epidemiological and clinical aspects of COVID-19: a narrative review. Arch Acad Emerg Med 2020; 8: e41.
    OpenUrl
  33. 33.↵
    1. Wölfel R,
    2. Corman VM,
    3. Guggemos W,
    4. Seilmaier M,
    5. Zange S,
    6. Müller MA, et al.
    Virological assessment of hospitalized patients with COVID-2019. Nature 2020; 581: 465–469.
  34. 34.↵
    National Institute of Infectious Diseases. COVID-19. [Updated 2021; accessed 2021 Mar 20]. Available from: https://www.niid.go.jp/niid/en/2019-ncov-e.html
  35. 35.↵
    1. Zheng S,
    2. Fan J,
    3. Yu F,
    4. Feng B,
    5. Lou B,
    6. Zou Q, et al.
    Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ 2020; 369: m1443.
    OpenUrl
  36. 36.↵
    The Lancet Haematology. COVID-19 coagulopathy: an evolving story. Lancet Haematol 2020; 7: e425.
    OpenUrl
  37. 37.↵
    1. Ceci FM,
    2. Fiore M,
    3. Gavaruzzi F,
    4. Angeloni A,
    5. Lucarelli M,
    6. Scagnolari C, et al.
    Early routine biomarkers of SARS-CoV-2 morbidity and mortality: outcomes from an emergency section. Diagnostics (Basel) 2022; 12: 176.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords